Snapshot from Sep 18, 2026 at 07:00 UTC. For live data and tracking: View Live
Business acquisition

Temple acquires Longevous longevity practice

Analysis based on 19 articles · First reported Aug 27, 2026 · Last updated Aug 27, 2026

Sentiment
30
Attention
4
Articles
19
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The acquisition strengthens Temple's clinical credibility ahead of its wearable launch, potentially boosting investor confidence and consumer interest. It may also signal growth in the longevity and healthtech sectors, positively impacting related startups and investors.

Health technology Wearable technology Longevity medicine

Temple, a healthtech wearable startup founded by Zomato, has acquired Longevous, a London-based evidence-based longevity medicine practice. The acquisition brings Longevous founders Dr Robert Mohr and Dr Avi Roy, along with their team, into Temple full-time. Mohr will serve as Chief Medical Officer, and Roy as Head of Science. The deal was announced by Goyal on X on August 27, 2026. Financial terms were not disclosed. Longevous will continue to operate as part of Temple, with its founders continuing to look after existing clients. The acquisition adds clinical and scientific expertise to Temple ahead of the planned launch of its wearable device, which tracks cerebral blood flow and oxygenation. The device features a proprietary metric called Entropy. Temple raised $54 million in February 2026 at a valuation of about $190 million, and its valuation doubled to $375 million following a secondary share sale in July 2026.

100 Temple acquired Longevous
70 Temple raised
60 Temple appointed Robert Mohr
60 Temple appointed Avi Roy
50 Temple launched ESOP
priv
Temple is the acquirer, gaining clinical and scientific expertise to support its wearable launch. The acquisition enhances its capabilities and may increase its valuation and market position.
Importance 100.0 Sentiment 70.0
per
As founder of Temple, Goyal announced the acquisition, strengthening his healthtech venture. The deal enhances his reputation in the longevity and wearable space.
Importance 90.0 Sentiment 70.0
priv
Longevous is acquired by Temple, with its founders joining full-time. The practice continues to operate under Temple, benefiting from Temple's resources and platform.
Importance 80.0 Sentiment 60.0
per
Mohr joins Temple as Chief Medical Officer, bringing clinical expertise. This role elevates his profile and allows him to influence Temple's health claims and experiments.
Importance 70.0 Sentiment 60.0
per
Roy joins Temple as Head of Science, contributing scientific leadership. His background in longevity research supports Temple's product development.
Importance 70.0 Sentiment 60.0
priv
Peak XV Partners is an investor in Temple. The acquisition may positively affect their investment's value.
Importance 30.0 Sentiment 50.0
priv
Steadview Capital is an investor in Temple. The acquisition may positively affect their investment's value.
Importance 30.0 Sentiment 50.0
priv
Dharana Capital is an investor in Temple. The acquisition may positively affect their investment's value.
Importance 30.0 Sentiment 50.0
priv
Razor s Edge Ventures is an investor in Temple. The acquisition may positively affect their investment's value.
Importance 30.0 Sentiment 50.0
stock
Zomato is mentioned as the company founded by Zomato, but is not directly involved in the acquisition. The event may indirectly reflect on Goyal's entrepreneurial activities.
Importance 20.0 Sentiment 40.0
priv
Founders Health is mentioned as a co-founding venture of Avi Roy. The event may bring attention to his other ventures.
Importance 15.0 Sentiment 40.0
oth
Uda is mentioned as a co-founding venture of Avi Roy. The event may bring attention to his other ventures.
Importance 15.0 Sentiment 40.0
Zomato related ↔ Zomato
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.